Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research
Background: Growing awareness of Alzheimer’s disease (AD) has boosted demand for quick and effective way to screen for memory loss and cognitive decline in a large number of individuals in society. Periodic Memory Screening Day events provide free, brief cognitive screening is intended for those 65 years and older, and can serve as an opportunity for participants to measure attitudes toward AD research and recruit them into research projects ongoing.
Methods: Over 6 one-day event in two years, more than 574 people individually filtered using a Moca and assignment story recall (immediate and delayed), are given feedback on their performance, and introduced the AD research and opportunities to participate.
Results: Screening classified 297 individuals (52.0%) as having “No Decline,” 192 (33.6%) as “The possibility of a decrease,” and 82 (14.4%) as “Likely decline.” Those with a “decline Likely” older and less educated, have more memory concerns, are more likely to be male, and less likely to have a positive family history of dementia compared with “No Decline.” subsequent validation of a screening procedure to full clinical evaluation revealed 72% classification accuracy with a leaning toward more-calling Possible and Likely reduction and thus guiding people questioned for a more thorough evaluation.
Of those screened, 378 (66%) agreed to additional research and approve research recorded in the registry, and the majority (70-85%) of approving reported they agreed to research the various AD procedures including lumbar puncture, MRI, and autopsy. Overall, 19.1% of those screened met the inclusion criteria for the ongoing study and successfully recruited to the study of AD.
Conclusion: Conducting the public memory is concentrated several screening events every year to help meet the public demand for a brief assessment of memory concerns and can be relatively effective recruitment strategies and efficient for AD research.

Attractive New Investigator Research into Alzheimer’s disease: Results from Increased Funding and Outreach
Since 2015, the National Institute on Aging (NIA), the National Institutes of Health (NIH), has experienced a significant increase in funding for Alzheimer’s disease and dementia related to Alzheimer’s disease (AD / ADRD). This analysis assessed the impact of these funds on workforce expansion AD / ADRD. NIA was given 860 awards to 695 AD / grantee ADRD R01 during the fiscal year 2015-2018. Twenty-nine percent of recipients that are new or early stage researchers, while 38% are new to the field of AD research / ADRD (NTF).
NTFS Among these, 59% established researchers, namely, the experts at NIH funding in other disciplines but only for AD / research ADRD. The next award is analyzed to determine the focus of their research is based on the International Alzheimer’s Disease Research Portfolio (IADRP) category. Forty-six percent focused on Molecular Pathogenesis and Physiology. Other IADRP categories, including Diagnosis, Assessment, and Monitoring Disease and Translational Research and Clinical Intervention, representing 5% -15% of the award.
![]() Total RNA from Alzheimer's Disease: Brain |
|||
R1236035Alz-50 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Alzheimer's Disease: Pons |
|||
R1236071Alz-10 | Biochain | 10 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total Protein from Parkinson's Disease: Brain: Occipital Lobe |
|||
P1236062Par | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Frontal Lobe |
|||
P1236051Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Parietal Lobe |
|||
P1236066Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Temporal Lobe |
|||
P1236078Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total RNA from Alzheimer's Disease: Corpus Callosum |
|||
R1236045Alz-10 | Biochain | 10 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Alzheimer's Disease: Postcentral Gyrus |
|||
R1236072Alz-10 | Biochain | 10 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Alzheimer's Disease: Precentral Gyrus |
|||
R1236073Alz-10 | Biochain | 10 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total Protein from Multiple Sclerosis Disease: Brain: Occipital Lobe |
|||
P1236062Msc | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Frontal Lobe (Alzheimer's Disease) Lysate |
|||
XBL-10282 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human frontal lobe tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human frontal lobe tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the frontal lobe tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The frontal lobe tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Parietal Lobe (Alzheimer's Disease) Lysate |
|||
XBL-10294 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human parietal lobe tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human parietal lobe tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the parietal lobe tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The parietal lobe tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Temporal Lobe (Alzheimer's Disease) Lysate |
|||
XBL-10314 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human temporal lobe tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human temporal lobe tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the temporal lobe tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The temporal lobe tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Genomic DNA from Alzheimer's Disease: Brain: Occipital Lobe, from a single donor |
|||
D1236062Alz | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Temporal Lobe (Alzheimer's Disease) Membrane Lysate |
|||
XBL-10312 | ProSci | 0.1 mg | EUR 626.75 |
Description: Human brain temporal lobe tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human temporal lobe tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated brain temporal lobe tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated brain temporal lobe tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
![]() Occipital Lobe |
|||
TB19005 | Neuromics | 0.1 gm | EUR 396 |
![]() Occipital Lobe |
|||
TB19012 | Neuromics | 5 Slides | EUR 422 |
![]() Total RNA from Human Adult Normal Tissue: Brain: Occipital Lobe |
|||
R1234062-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total Protein from Dementia: Brain: Occipital Lobe |
|||
P1236062Dem | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Depression: Brain: Occipital Lobe |
|||
P1236062Dep | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() cDNA from Alzheimer's Disease: Brain: Frontal Lobe |
|||
C1236051Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Parietal Lobe |
|||
C1236066Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Temporal Lobe |
|||
C1236078Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total Protein from Alzheimer's Disease: Brain |
|||
P1236035Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Occipital Lobe Lysate |
|||
1370 | ProSci | 0.1 mg | EUR 191 |
Description: Occipital Lobe tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
![]() Frozen Tissue Section - Parkinson's Disease: Brain: Occipital Lobe |
|||
T1236062Par | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Paraffin Tissue Section - Alzheimers Disease: Brain: Occipital Lobe |
|||
T2236062Alz | Biochain | 5 slides | EUR 257 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Paraffin Tissue Section - Parkinson's Disease: Brain: Occipital Lobe |
|||
T2236062Par | Biochain | 5 slides | EUR 257 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Frozen Tissue Section - Alzheimer's Disease: Brain: Frontal Lobe |
|||
T1236051Alz | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Frozen Tissue Section - Alzheimer's Disease: Brain: Parietal Lobe |
|||
T1236066Alz | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Frozen Tissue Section - Alzheimer's Disease: Brain: Temporal Lobe |
|||
T1236078Alz | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Total Protein from Alzheimer's Disease: Brain: Amygdala |
|||
P1236036Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Cerebellum |
|||
P1236039Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Hippocampus |
|||
P1236052Alz | Biochain | 1 mg | EUR 556 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Pons |
|||
P1236071Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Thalamus |
|||
P1236079Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Frozen Tissue Section - Multiple Sclerosis Disease: Brain: Occipital Lobe |
|||
T1236062Msc | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Paraffin Tissue Section - Multiple Sclerosis Disease: Brain: Occipital Lobe |
|||
T2236062Msc | Biochain | 5 slides | EUR 257 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Total RNA from Human Adult Normal Tissue 5 Donor Pool: Brain: Occipital Lobe |
|||
R1234062-P | Biochain | 50 ug | EUR 328 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Occipital Lobe Membrane Lysate |
|||
XBL-10184 | ProSci | 0.1 mg | EUR 516.5 |
Description: Human brain occipital lobe tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human occipital lobe tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated brain occipital lobe tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated brain occipital lobe tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
![]() Total Protein from Progressive Supranuclear Palsy: Brain: Occipital Lobe |
|||
P1236062PSP | Biochain | 1 mg | EUR 556 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Corpus Callosum |
|||
P1236045Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Medulla oblongata |
|||
P1236057Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Postcentral Gyrus |
|||
P1236072Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Alzheimer's Disease: Brain: Precentral Gyrus |
|||
P1236073Alz | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Human Adult Normal Tissue: Brain: Occipital Lobe |
|||
P1234062 | Biochain | 1 mg | EUR 214 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Parkinson's Disease: Brain: Frontal Lobe |
|||
P1236051Par | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Parkinson's Disease: Brain: Parietal Lobe |
|||
P1236066Par | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Parkinson's Disease: Brain: Temporal Lobe |
|||
P1236078Par | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total RNA from Diabetic Disease: Colon |
|||
R1236090Dia-50 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Diabetic Disease: Esophagus |
|||
R1236106Dia-50 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Diabetic Disease: Pancreas |
|||
R1236188Dia-50 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Diabetic Disease: Stomach |
|||
R1236248Dia-50 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Amygdala (Alzheimer's Disease) Lysate |
|||
XBL-10274 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human amygdala tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human amygdala tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the amygdala tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The amygdala tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Hippocampus (Alzheimer's Disease) Lysate |
|||
XBL-10286 | ProSci | 0.1 mg | EUR 768.5 |
Description: Human hippocamps tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human hippocamps tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the hippocamps tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The hippocamps tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Pons (Alzheimer's Disease) Lysate |
|||
XBL-10298 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human pons tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pons tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pons tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pons tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Thalamus (Alzheimer's Disease) Lysate |
|||
XBL-10310 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human thalamus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human thalamus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the thalamus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The thalamus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Total Protein from Multiple Sclerosis Disease: Brain: Frontal Lobe |
|||
P1236051Msc | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Multiple Sclerosis Disease: Brain: Parietal Lobe |
|||
P1236066Msc | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total Protein from Multiple Sclerosis Disease: Brain: Temporal Lobe |
|||
P1236078Msc | Biochain | 1 mg | EUR 461 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total RNA from Congenital heart disease: Heart |
|||
R1236122Hd-3 | Biochain | 50 ug | EUR 351 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Genomic DNA from Parkinson's Disease: Brain: Occipital Lobe, from a single donor |
|||
D1236062Par | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Genomic DNA from Alzheimer's Disease: Brain: Frontal Lobe, from a single donor |
|||
D1236051Alz | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Genomic DNA from Alzheimer's Disease: Brain: Parietal Lobe, from a single donor |
|||
D1236066Alz | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Genomic DNA from Alzheimer's Disease: Brain: Temporal Lobe, from a single donor |
|||
D1236078Alz | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Genomic DNA from Multiple Sclerosis Disease: Brain: Occipital Lobe, from a single donor |
|||
D1236062Msc | Biochain | 50 ug | EUR 446 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Human Alzheimer's Disease Primer Library |
|||
HAZD-I | Real Time Primers | 1 set | EUR 548 |
![]() cDNA from Alzheimer's Disease: Brain |
|||
C1236035Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Amygdala (Alzheimer's Disease) Membrane Lysate |
|||
XBL-10272 | ProSci | 0.1 mg | EUR 626.75 |
Description: Human brain amygdala tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human amygdala tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated brain amygdala tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated brain amygdala tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
![]() Corpus Callosum (Alzheimer's Disease) Lysate |
|||
XBL-10278 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human corpus Callosum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human corpus Callosum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the corpus Callosum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The corpus Callosum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Hippocampus (Alzheimer's Disease) Cytoplasmic Lysate |
|||
XBL-10283 | ProSci | 0.1 mg | EUR 227.75 |
Description: Human brain hippocamps tissue cytoplasmic protein lysate was prepared by isolating the cytoplasmic protein from whole tissue homogenates using a proprietary technique. The human hippocamps tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The cytoplasmic protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, glycerol, and a cocktail of protease inhibitors. For quality control purposes, the isolated brain hippocamps tissue cytoplasmic protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated brain hippocamps tissue cytoplasmic protein is then Western analyzed by GAPDH antibody, and the expression level is consistent with each lot. |
![]() Hippocampus (Alzheimer's Disease) Membrane Lysate |
|||
XBL-10284 | ProSci | 0.1 mg | EUR 710.75 |
Description: Human brain hippocamps tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human hippocamps tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated brain hippocamps tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated brain hippocamps tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
![]() Postcentral Gyrus (Alzheimer's Disease) Lysate |
|||
XBL-10302 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human postcentral gyrus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human postcentral gyrus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the postcentral gyrus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The postcentral gyrus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Precentral Gyrus (Alzheimer's Disease) Lysate |
|||
XBL-10306 | ProSci | 0.1 mg | EUR 663.5 |
Description: Human precentral gyrus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human precentral gyrus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the precentral gyrus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The precentral gyrus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
![]() Frozen Tissue Section - Dementia: Brain: Occipital Lobe |
|||
T1236062Dem | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Frozen Tissue Section - Depression: Brain: Occipital Lobe |
|||
T1236062Dep | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Paraffin Tissue Section - Dementia: Brain: Occipital Lobe |
|||
T2236062Dem | Biochain | 5 slides | EUR 257 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Paraffin Tissue Section - Depression: Brain: Occipital Lobe |
|||
T2236062Dep | Biochain | 5 slides | EUR 257 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Total RNA from Human Adult Normal Tissue: Brain: Frontal Lobe |
|||
R1234051-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Human Adult Normal Tissue: Brain: Parietal Lobe |
|||
R1234066-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Human Adult Normal Tissue: Brain: Temporal Lobe |
|||
R1234078-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Human Adult Normal Tissue: Liver: Left Lobe |
|||
R1234150-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Human Adult Normal Tissue: Liver: Right Lobe |
|||
R1234151-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Amygdala |
|||
C1236036Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Cerebellum |
|||
C1236039Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Hippocampus |
|||
C1236052Alz | Biochain | 40 reactions | EUR 801 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Pons |
|||
C1236071Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() cDNA from Alzheimer's Disease: Brain: Thalamus |
|||
C1236079Alz | Biochain | 40 reactions | EUR 668 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Frozen Tissue Section - Alzheimer's Disease: Brain |
|||
T1236035Alz | Biochain | 5 slides | EUR 465 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
![]() Membrane Protein from Alzheimer's Disease:Brain: Temporal Lobe |
|||
P3236078Alz | Biochain | 0.1 mg | EUR 408 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
![]() Total RNA from Human Adult Normal Tissue: Lung: Left Lower Lobe |
|||
R1234155-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
![]() Total RNA from Human Adult Normal Tissue: Lung: Left Upper Lobe |
|||
R1234156-50 | Biochain | 50 ug | EUR 178 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
Significantly, the researchers NTF receive 50%, 42%, and 70% of the total grants awarded in Population Studies, Dementia Care, and Brain Aging, respectively, indicating that the NTF researchers fill research gaps. While these results suggest that increased funding associated with the recruitment of new talent, the opportunities for further growth remain, particularly with regard to treatment, care, and health inequalities.